Clinical Research Directory

Inclusion Criteria: * Patients with a previous diagnosis of type B aortic dissection or intramural hematoma or penetrating ulcer, who underwent endovascular aortic repair (EVAR) or EVAR + supra-aortic shunt surgery for more than 1 month, and no related complications (such as endoleak, stent thrombosis, dissection progression, etc.) were found in the postoperative aortic CTA; * Able to independently carry out basic daily life activities, participants must be able to complete the baseline assessment and start the designated treatment; * Patients voluntarily participate in this study, sign the written informed consent, and are willing to cooperate with the follow-up; Exclusion Criteria: * Acute myocardial infarction occurred 1 month ago; * Combined with severe aortic stenosis or regurgitation; * Combined with ascending aortic aneurysm or dissection; * Acute heart failure occurred 2 weeks ago; * Combined with severe hypertrophic obstructive cardiomyopathy; * Chronic renal failure stage 5, which is defined as glomerular filtration rate \<15ml/(min·1.73m2) or dialysis; * During the screening examination, the patient's alanine aminotransferase or aspartate aminotransferase is greater than or equal to 5 times the upper limit of the normal value specified by our center; * Patients with any medical history that may affect compliance with the program; * Patients with severe language, mental or physical disabilities who are unable to participate in the program; * Pregnant or lactating women, or those with fertility who are unwilling/unable to take effective contraceptive measures; * Patients participating in other interventional clinical trials; * Patients with long-term high-intensity exercise habits; * Patients who are judged by the researchers to be unsuitable for participation in this study;